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Evaluation of prostaglandin F2α in addition to a conventional treatment of retained 
placenta in dairy cows.  
 
In a field trial etiproston (Prostavet®), a synthetic analogue of prostaglandin F2α was used 
therapeutically, i.e. after diagnosis of retained placenta (fetal membranes were considered 
retained if not expelled within twelve hours after parturition). The trial was conducted from 
June 1998 to November 1999 on three commercial dairy farms in Brandenburg, Germany. A 
total of 293 cows were enrolled in the study. After withdrawal of animals not fitting the 
treatment protocol, finally 229 cows were eligible for statistical analysis. On farm A, B and C 
a total of 77, 62 and 90 cows respectively, remained in the study.  
In both groups an attempt was made to carefully remove the fetal membranes. After the 
manipulation an intrauterine antibiotic treatment was administered (treated controls). Cows of 
the experimental group received a supplementary intramuscular injection of 4 mg etiproston 
(2 ml Prostavet®) at every treatment. Therapy was continued in two to three day intervals until 
the placenta was expelled. Animals with rectal temperatures exceeding 39,5°C were 
systemically treated with antibiotics.  
All cows were examined for endometritis by rectal palpation between days 14 to 20 post 
partum. Animals that showed signs of endometritis were treated with PGF2α (4 mg 
etiproston). Afterwards they were re-examined two weeks later and in case of endometritis 
treated again in the same way. The parameters used to measure subsequent reproductive 
performance were days to first service, days open, service rate, first service conception rate, 
services per conception and conception rate. Cows not inseminated or found not pregnant at a 
pre determined time post partum were examined by rectal palpation and treated accordingly. 
Repeated monthly test day milk yield (Fat Corrected Milk, FCM) was used to evaluate the 
effect of etiproston treatment during the first four months post partum. The history of each 
animal was observed up to next pregnancy, culling of the cow or until day 200 post partum.  
 
Short-term effects 
Time from calving to placental expulsion was shorter in the etiproston treated group on farm 
B (p < 0,05). Cows in the experimental group on farm A required more treatments for retained 
placenta than those of the control group (p < 0,05). On farm C the number of cows 
systemically treated with antibiotics because of fever was significantly lower in the etiproston 
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treated group (p < 0,05). A positive influence of calving management on this farm, differing 
from farms A and B, has been supposed. During the first 20 days p.p. on farm B the animals 
in the experimental group had less cases of mastitis (p < 0,05), but incidence of other diseases 
did not differ significantly between study groups on all farms.  
 
Medium-term effects 
Concerning prevalence of endometritis there was no difference between the experimental 




Treatment of retained placenta with etiproston had no significant effect on reproductive 
performance on all farms. Causes for infertility did not differ between the study groups on all 
farms as well.  
 
Culling, milk yield 
Culling frequencies did not differ significantly between the study groups on all farms. On the 
other hand on farm C more cows of the experimental group were excluded from breeding and 
considered culled (p < 0,05), but these were complex management decisions of the farm itself. 
Therefore this difference seemed to be accidental.  
Regarding milk yield there were no statistical differences between the study groups on all 
farms.  
 
The additional use of prostaglandin F2α for treatment of retained fetal membranes had some 
short term effects. However, each effect was achieved on only one of the farms participating 
in the trial. Differences were not always in favour of the experimental group. Thus the 
therapeutic regimen in the experimental groups was not cost effective, because especially 
long-term effects failed to appear.  
 
 
